PRE News and Press, Prenetics Global Limited From 09/08/23

Prenetics Global Limited (PRE) is expected to report for Q2 2023

(NewsDirect) Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its f...

(Prof. Dennis Lo and Danny Yeung at Signing Ceremony) - Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics which is supported by the InnoHK Initiative of the Innovation and Technology Commission...

2023-06-05 07:34:18 ET Prenetics Global press release ( NASDAQ: PRE ): Q1 GAAP EPS of -$0.07. Revenue of $17.7M (-80.8% Y/Y). For further details see: Prenetics Global GAAP EPS of -$0.07, revenue of $17.7M

HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the first quarter ended March 31, 2023, along with recent busine...

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology LONDON AND HONG KONG, Mar 14, 2023 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision ...

2023-03-14 08:59:03 ET Prenetics Global press release ( NASDAQ: PRE ): Q4 GAAP EPS of $0.01. Revenue of $52.3M (-19.2% Y/Y). Gross margin was 51.6% for the fourth quarter 2022 compared to 36.7% for the fourth quarter 2021. Profit from operations was US$4.6 million ...

LONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, ...

LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the ‘SAB’) to provide strategic input based on their scientif...

LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from ...